MARKET

ISEE

ISEE

IVERIC bio Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.95
-0.22
-3.57%
After Hours: 5.95 0 0.00% 16:00 04/16 EDT
OPEN
6.25
PREV CLOSE
6.17
HIGH
6.29
LOW
5.93
VOLUME
425.34K
TURNOVER
--
52 WEEK HIGH
7.98
52 WEEK LOW
3.510
MARKET CAP
536.51M
P/E (TTM)
-5.1551
1D
5D
1M
3M
1Y
5Y
New Strong Sell Stocks for April 6th
Zacks · 04/06 16:16
Iveric Bio Chairman to step down
IVERIC bio ([[ISEE]] -2.6%) says its co-founder and Executive Chairman David R. Guyer is stepping down from the board after the company’s 2021 Annual Stockholder Meeting scheduled for May 19, 2021. Dr.
Seekingalpha · 04/05 16:51
David R. Guyer, MD to Step Down from Iveric Bio Board to Rejoin Venture Fund
Iveric Bio today announced that David R. Guyer, MD, co-founder and Executive Chairman, is stepping down from the Iveric Bio Board after 14 years.
Business Wire · 04/05 11:45
DJ Iveric Bio Chairman Guyer to Step Down, Rejoin SV Health Investors
Dow Jones · 04/05 10:55
BRIEF-David R. Guyer, MD To Step Down From Iveric Bio Board To Rejoin Venture Fund
reuters.com · 04/05 10:46
IVERIC Bio: Guyer Will Rejoin SV Health Investors as a Venture Partner >ISEE
IVERIC Bio: Guyer Will Rejoin SV Health Investors as a Venture Partner >ISEE
Dow Jones · 04/05 10:46
IVERIC Bio: Guyer Stepping Dn From Bd After 14 Years Effective Following 2021 Annual Stockholder Meeting >ISEE
IVERIC Bio: Guyer Stepping Dn From Bd After 14 Years Effective Following 2021 Annual Stockholder Meeting >ISEE
Dow Jones · 04/05 10:46
David Guyer to Step Down From Iveric Bio Board to Rejoin Venture Fund
David Guyer to Step Down From Iveric Bio Board to Rejoin Venture Fund
Dow Jones · 04/05 10:45
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ISEE. Analyze the recent business situations of IVERIC bio Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ISEE stock price target is 13.33 with a high estimate of 15.00 and a low estimate of 11.00.
EPS
Institutional Holdings
Institutions: 183
Institutional Holdings: 87.06M
% Owned: 96.55%
Shares Outstanding: 90.17M
TypeInstitutionsShares
Increased
38
10.65M
New
37
5.07M
Decreased
28
6.49M
Sold Out
18
4.86M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.60%
Pharmaceuticals & Medical Research
+0.89%
Key Executives
Chairman/Executive Director
David Guyer
President/Chief Executive Officer/Director
Glenn Sblendorio
Chief Financial Officer/Senior Vice President/Treasurer
David Carroll
Chief Operating Officer/Senior Vice President
Keith Westby
Executive Vice President
Pravin Dugel
Chief Scientific Officer
Abraham Scaria
Lead Director/Independent Director
Adrienne Graves
Director
Mark Blumenkranz
Independent Director
Axel Bolte
Independent Director
Jane Henderson
Independent Director
Calvin Roberts
No Data
  • All
  • Financials
  • Insiders
More
About ISEE
IVERIC bio, Inc. is a biopharmaceutical company. The Company is focused on the discovering and developing of treatment options for retinal diseases. The Company is developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases (IRDs). The Company’s therapeutics portfolio consists of its clinical stage product candidate Zimura (avacincaptad pegol), a complement C5 inhibitor, and IC-500, its preclinical product candidate from its High temperature requirement A serine peptidase one protein (HtrA1), inhibitors program. Its lead gene therapy products also includes IC-100 and IC-200.

Webull offers kinds of IVERIC bio Inc stock information, including NASDAQ:ISEE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ISEE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ISEE stock methods without spending real money on the virtual paper trading platform.